Ajili F1, Kacem M, Tounsi H, et al. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34[J]. Ultrastruct Pathol, 2012, 36(5):336-342.
[3]
Kouba EJ, Lentz A, Wallen EM, et al. Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.[J]. Urol Oncol, 2009, 27(5):486-490.
Richards KA, Smith ND, Steinberg GD. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer:a systematic review of novel technologies[J].J Urol, 2014,1:87.
Sandhu JS, Ng CA, Conzalez R, et al. High-power KTP Photoselectivelaser vaporization prostatectomy in man with largeprostative:the New York Presbyterian series of 64 patients[J]. J Urol, 2004, 171(suppl):400.
[8]
Rosser CJ, Dai Y, Miyake M, et al. Simultaneous multi-analyte urinary protein assay for bladder cancer detection[J]. BMC Biotechnol, 2014, 14(1):24.
[9]
Kunze E, Wendt M, Schlott T. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas[J]. Int J Mol Med, 2006, 18(4):547-557.
